Top-line Results In Phase Ii Clinical Trial Of Etns For Treatment Of Depression

(NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive external trigeminal nerve stimulation (eTNS) technology for the treatment of neurological and neuropsychiatric disorders, applauds the accomplishments of an independent team of Brazilian researchers led by Pedro Shiozawa, M.D., on their positive top-line findings from a Phase II clinical trial of eTNS as adjunctive treatment for major depressive disorder (MDD). The trial was conducted at the... Top-line Results In Phase Ii Clinical Trial Of Etns For Treatment Of Depression
https://www.myptsd.com/c/threads/top-line-results-in-phase-ii-clinical-trial-of-etns-for-treatment-of-depression.49138/